Cns Pharmaceuticals, Inc. · NASDAQ:CNSP

Stonepine Capital Management, LLC reported a 5.60% stake in Cns Pharmaceuticals, Inc. (Schedule 13G)

Event Oct 29, 2025 · Filed Nov 4, 2025

Stonepine Capital Management, LLC reported a 5.60% stake in Cns Pharmaceuticals, Inc., 32,220 shares, as a passive investor on Oct 29, 2025. Filed Nov 4, 2025 (Schedule 13G).

Stake
5.60%
Shares
32,220
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Stonepine Capital Management, LLC5.60%32,220
Stonepine Capital, L.P.5.60%32,220
Stonepine GP, LLC5.60%32,220
Jon M. Plexico5.60%32,220

Source

View original at SEC

Related